Norges Bank’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-440,168
| Closed | -$75.8M | – | 2347 |
|
|
2021
Q3 | $75.8M | Buy |
440,168
+21,820
| +5% | +$2.85M | 0.02% | 733 |
|
|
2021
Q2 | $52.5M | Sell |
418,348
-6,675
| -2% | -$842K | 0.01% | 938 |
|
|
2021
Q1 | $57.6M | Sell |
425,023
-52,632
| -11% | -$6.8M | 0.01% | 898 |
|
|
2020
Q4 | $61.1M | Hold |
477,655
| – | – | 0.01% | 841 |
|
|
2020
Q3 | $53.8M | Buy |
477,655
+15,189
| +3% | +$1.51M | 0.01% | 808 |
|
|
2020
Q2 | $44.1M | Sell |
462,466
-87,762
| -16% | -$8.46M | 0.01% | 917 |
|
|
2020
Q1 | $49.4M | Hold |
550,228
| – | – | 0.02% | 704 |
|
|
2019
Q4 | $29.2M | Buy |
550,228
+14,323
| +3% | +$653K | 0.01% | 1293 |
|
|
2019
Q3 | $21.2M | Buy |
535,905
+40,260
| +8% | +$1.75M | 0.01% | 1451 |
|
|
2019
Q2 | $20.4M | Buy |
495,645
+26,281
| +6% | +$1.09M | 0.01% | 1493 |
|
|
2019
Q1 | $21.9M | Buy |
469,364
+66,712
| +17% | +$2.93M | 0.01% | 1446 |
|
|
2018
Q4 | $17.5M | Hold |
402,652
| – | – | 0.01% | 1481 |
|
|
2018
Q3 | $23M | Hold |
402,652
| – | – | 0.01% | 1443 |
|
|
2018
Q2 | $19.5M | Hold |
402,652
| – | – | 0.01% | 1543 |
|
|
2018
Q1 | $15.7M | Hold |
402,652
| – | – | 0.01% | 1569 |
|
|
2017
Q4 | $17.1M | Hold |
402,652
| – | – | 0.01% | 1544 |
|
|
2017
Q3 | $15M | Buy |
402,652
+80,000
| +25% | +$2.78M | 0.01% | 1592 |
|
|
2017
Q2 | $9.8M | Hold |
322,652
| – | – | ﹤0.01% | 1745 |
|
|
2017
Q1 | $8.54M | Hold |
322,652
| – | – | ﹤0.01% | 1784 |
|
|
2016
Q4 | $8.23M | Hold |
322,652
| – | – | ﹤0.01% | 1758 |
|
|
2016
Q3 | $11.2M | Buy |
322,652
+132,736
| +70% | +$4.4M | 0.01% | 1592 |
|
|
2016
Q2 | $6.45M | Buy |
189,916
+155,116
| +446% | +$5.04M | ﹤0.01% | 1793 |
|
|
2016
Q1 | $918K | Buy |
34,800
+4,800
| +16% | +$140K | ﹤0.01% | 2070 |
|
|
2015
Q4 | $1.46M | Hold |
30,000
| – | – | ﹤0.01% | 2069 |
|
|
2015
Q3 | $747K | Buy |
+30,000
| New | +$902K | ﹤0.01% | 2149 |
|
Norges Bank's XLRN Position: Q4 2021 in Review
Norges Bank sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 440,168 shares — an estimated $75.8M sold.
Norges Bank first reported a position in XLRN in Q3 2015 and held it in 25 quarters. The position peaked at $75.8M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Norges Bank reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Norges Bank sold 440,168 Acceleron Pharma shares in Q4 2021, an estimated $75.8M.
- Norges Bank first reported a position in Acceleron Pharma in Q3 2015 and held it in 25 quarters.
- Norges Bank's Acceleron Pharma position peaked at $75.8M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Norges Bank's 13F filing for Q4 2021, filed 10 Feb 2022.